Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). Annals of oncology : official journal of the European Society for Medical Oncology Wakelee, H., Reckamp, K. L., Leal, T. A., Patel, S. P., Blumenschein, G., Shum, E., Nieva, J., Oxnard, G., Sanborn, R. E., Waqar, S., Zeman, K., Dukart, G., Harrow, K., Liang, C., Holzhausen, A., Horn, L. 2018; 29 Suppl 8: viii541–viii542
View details for DOI 10.1093/annonc/mdy292.117
View details for PubMedID 32137409